glutathione synthesis inhibitor Combined inhibition of de novo
Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma ScienceDirect Frontiers The versatile utility of cysteine as a target for cancer treatment Frontiers Preclinical investigations of the efficacy of the glutaminase inhibitor CB 839 alone and in combinations in chronic lymphocytic leukemia A mouse model to study glutathione limitation in vivo bioRxiv
Pay in 4 interest-free payments of $7.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30



